2026-01-04 - Analysis Report
Okay, here's a comprehensive analysis of Procter & Gamble (PG) based on the provided data.

**0) Report in English**

**1) Return Rate Comparison (PG vs. S&P 500)**

*   **Company Overview:** Procter & Gamble Co. is a global consumer goods company that manufactures and markets a wide range of branded consumer packaged goods.
*   **PG Cumulative Return:** 18.59%
*   **VOO (S&P 500) Cumulative Return:** 91.00%
*   **Divergence:** -71.4 (Relative Divergence: 4.1)

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha  | Beta  | Cap(B) |
|------------|---------|-------|--------|-------|--------|
| 2016-2018  | 4.0%    | 10.7% | 1.0%   | 0.5   | 215.1  |
| 2017-2019  | 23.0%   | 10.7% | 5.0%   | 0.5   | 292.3  |
| 2018-2020  | 26.0%   | 17.9% | 5.0%   | 0.7   | 325.7  |
| 2019-2021  | 39.0%   | 17.9% | -5.0%  | 0.7   | 382.9  |
| 2020-2022  | 11.0%   | 17.9% | 13.0%  | 0.6   | 354.7  |
| 2021-2023  | 24.0%   | 15.9% | 23.0%  | 0.4   | 343.0  |
| 2022-2024  | 7.0%    | 15.9% | -12.0% | 0.4   | 392.4  |
| 2023-2025  | -19.0%  | 21.6% | -81.0% | 0.2   | 335.4  |

**Analysis:**

*   PG has significantly underperformed the S&P 500 over the period examined. The -71.4 divergence (with a relative divergence of 4.1) indicates that PG's underperformance is near the lowest end of its historical range relative to the S&P 500. This suggests potential for reversion to the mean (outperformance in the future).
*   The Alpha/Beta analysis shows that in recent periods (2022-2025, 2023-2025), PG's alpha has been significantly negative, especially in the last period. This means PG has underperformed relative to what its beta (sensitivity to market movements) would suggest. Beta has been relatively low (0.2-0.7), indicating lower volatility than the overall market.
* CAGR has been negative recently in 2023-2025 period, and MDD has been highest in the same period.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 141.79
*   **Previous Close:** 143.31
*   **Change:** -1.06
*   **5-day SMA:** 143.69
*   **20-day SMA:** 143.36
*   **60-day SMA:** 146.97

**Analysis:**

*   The stock price is currently below all three moving averages, suggesting a short-term downward trend.  The 5-day SMA is closest to the current price, but still above it.  The 60-day SMA is significantly higher, reinforcing the downward trend indication.

**3) RSI, PPO, Divergence, and Expected Return**

*   **MRI:** 0.8 (Medium Investment Recommended)
*   **RSI:** 52.99
*   **PPO:** 0.03
*   **Hybrid Signal:** Cash_0%_Buy 90% of cash (6 shares - Safe - MRI:0.80). Monthly invest 0.8% of total investment ($1,000.00)
*   **Recent Divergence Change (20 days):** 1.8 (+): 단기상승 (Short-term increase)
*   **Expected Return:** 15.8% (Long-term excess return compared to S&P 500)

**Analysis:**

*   The MRI of 0.8 suggests a medium level of investment risk and provides a positive signal.
*   The RSI of 52.99 is neutral, indicating neither overbought nor oversold conditions.
*   The PPO is near zero, indicating that the short-term and long-term moving averages are close to each other, suggesting consolidation.
*   The Hybrid Signal recommends buying 90% of cash with monthly investments and supports the MRI recommendation.
*   The recent increase in relative divergence suggests a short-term upward movement relative to the S&P 500.
*   The Expected Return of 15.8% is attractive, promising outperformance over the S&P 500 in the long term.
*   The 'change' of -1.06 with a prior close of 143.31 is not relatively large, but is slightly down.

**4) Recent News & Significant Events (Yahoo Finance):**

*   **[2025-12-19] Shares of P&G Struggled in 2025. What Will It Do in 2026? - The Motley Fool:** This headline indicates concerns about PG's recent performance and raises questions about its future prospects.
*   **[2025-12-13] Jim Cramer on Procter & Gamble: “Patience Is Going to Pay off With PG” - Yahoo Finance:** This suggests a positive outlook, implying that PG is a good long-term investment.
*   **[2026-01-03] Merit Financial Group LLC Raises Stock Position in Procter & Gamble Company (The) $PG - MarketBeat:** This is a positive signal, suggesting confidence in the company's future.
*   **[2026-01-01] P&G stock ends 2025 lower as Wall Street slips — what to watch before trading resumes - ts2.tech:** This reinforces the concern about PG's recent underperformance.
*   **[2025-12-16] Jim Cramer identifies his favorite portfolio stock — and it’s not a big tech name - CNBC:** This is a positive signal from Jim Cramer, implying that PG is a good investment.
*   **[2025-12-17] Buy PG Stock Over Colgate-Palmolive? - Forbes:** This suggests a favorable comparison to a competitor, indicating positive sentiment.

**Analysis:**

*   The news headlines present a mixed picture. While some articles highlight struggles in 2025 and raise concerns, others (particularly Jim Cramer's comments and Merit Financial's increased position) suggest potential for future gains.

**4-2) Analyst Opinions**

*   **Consensus:** Buy
*   **Mean:** 1.92 (Buy)
*   **Opinions:** 22
*   **Target Price (avg/high/low):** 168.95 / 186.00 / 148.00

**Analysis:**

*   Analyst consensus is "Buy" with an average target price of $168.95, suggesting significant upside potential from the current price of $141.79. This is a strong positive indicator.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출        |
|------------|------|-------------|
| 2025-10-24 | 2    | 22.39 B$    |
| 2025-04-24 | 1.58 | 19.78 B$    |
| 2025-01-22 | 1.94 | 21.88 B$    |
| 2024-10-18 | 1.65 | 21.74 B$    |
| 2025-10-24 | 1.65 | 21.74 B$    |

**Analysis:**

*   Revenue has fluctuated between $19.78B and $22.39B. The most recent quarter (2025-10-24) shows the highest revenue.
*   EPS also varies, with the highest EPS being 2 (2025-10-24) and lowest being 1.58 (2025-04-24).
*   Generally, the earnings data shows positive momentum.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $22.39B    | 51.37%        |
| 2025-06-30   | $20.89B    | 49.11%        |
| 2025-03-31   | $19.78B    | 50.98%        |
| 2024-12-31   | $21.88B    | 52.39%        |
| 2024-09-30   | $21.74B    | 52.06%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE   |
|--------------|------------|-------|
| 2025-09-30   | $53.27B    | 8.92% |
| 2025-06-30   | $52.01B    | 6.95% |
| 2025-03-31   | $52.27B    | 7.21% |
| 2024-12-31   | $51.17B    | 9.05% |
| 2024-09-30   | $51.84B    | 7.64% |

**Analysis:**

*   **Revenue and Profitability:** Revenue fluctuates, with the most recent quarter showing the highest revenue. Profit margins are consistently high, ranging from approximately 49% to 52%. This indicates strong pricing power and efficient cost management.
*   **Capital and Profitability:** Equity is increasing over the observed period. ROE (Return on Equity) fluctuates, but is generally healthy, ranging from 6.95% to 9.05%. This indicates that PG is effectively generating profits from its shareholders' investments.

**7) Comprehensive Analysis**

Procter & Gamble (PG) presents a mixed investment picture based on the provided data.

**Negative Signals:**

*   **Significant Underperformance vs. S&P 500:** PG has significantly lagged the S&P 500 in terms of cumulative return, and this underperformance is near the low end of its historical range.
*   **Recent Negative Alpha:** The recent negative alpha values indicate that PG has not been performing as well as expected based on its market sensitivity (beta).

**Positive Signals:**

*   **Analyst Consensus "Buy":** The strong analyst consensus, along with a significant average price target, suggests potential upside.
*   **Solid Financials:** PG demonstrates strong revenue and high-profit margins and good and Equity and ROE.
*   **MRI Score:** MRI indicates a medium level of investment risk and provides a positive signal.

**Mixed Signals:**

*   **Recent News:** The news headlines present a conflicting view, with some articles raising concerns about PG's performance while others express optimism.
*   **Moving Averages and Recent Price Action:** Short-term price action is trending downward, while the recent relative divergence change signals a possible short-term uptick.
*   **Hybrid Signal:** recommends to buy 90% of cash which means a optimistic signal in general.

**Overall Recommendation:**

PG appears to be a potentially interesting turnaround play. The significant underperformance relative to the S&P 500, coupled with negative recent alpha, suggests caution. However, the strong analyst consensus, healthy financials, and positive MRI score offer reasons for optimism. The 15.8% expected long-term return is an attractive feature.

**Before investing, it's crucial to:**

1.  **Do further research:** Analyze PG's competitive landscape, future growth prospects, and potential risks in greater detail.
2.  **Monitor news and earnings reports:** Stay informed about the company's performance and any significant events that could impact its stock price.
3.  **Consider your risk tolerance:** Weigh the potential rewards against the risks associated with investing in PG, particularly given its recent underperformance.

In conclusion, a cautious approach is warranted, but the positive signals and turnaround potential make PG worth further investigation. Consider dollar-cost averaging to gradually build a position.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.